Skip to main content

Advertisement

Log in

Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo

  • ORIGINAL CONTRIBUTION
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Abstract

Platelet adhesion to the atherosclerotic vascular wall induces thrombosis and boosters vascular inflammation and atheroprogression. In the present study we studied the binding of the platelet collagen receptor glycoprotein (GP) VI to human atherosclerotic plaques (AP) and the role of GPVI-mediated platelet adhesion for atheroprogression. Soluble GPVI-Fc fusion protein bound to immobilized collagen type I, collagen type III, and predominantly to the core region of human carotid atheromatous plaques. The pattern of GPVI-Fc binding was similar to the immunostaining pattern of collagen type III and differed from the immunostaining of collagen type I, which was more intense in the cap than in the core. Plaque-induced platelet aggregation in stirred blood and platelet adhesion/aggregate formation under flow were inhibited by the anti-GPVI monoclonal antibody 5C4 or by pretreatment of plaques with anti-collagen type I and anti-collagen type III antibody, or GPVI-Fc. However, there was no correlation between GPVI-Fc binding and platelet aggregating activity of individual plaques. GPVI bound also to atherosclerotic arteries of ApoE-deficient mice in vivo as assessed by small animal positron emission tomography (PET). Prolonged administration of soluble GPVI attenuated atheroprogression in ApoE-deficient mice. In humans, GPVI binding to collagenous type I and type III structures of the plaque core region mediates plaque-induced platelet adhesion and aggregation, but GPVI binding is not the sole platelet-activating determinant of plaques. In mice, GPVI-mediated platelet adhesion to the atherosclerotic vascular wall is involved in atheroprogression in vivo. Taken together, our data suggests that GPVI is a relevant target to prevent atherothrombotic events and atheroprogression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Alevriadou BR, McIntire LV (1995) Rheology. Loscalzo J, Schafer AI (eds) Thrombosis and hemorrhage. Blackwell, Cambridge, pp 369–384

    Google Scholar 

  2. Brandl R, Richter T, Haug K, Wilhelm MG, Maurer PC, Nathrath W (1997) Topographic analysis of proliferative activity in carotid endarterectomy specimens by immunocytochemical detection of the cell cycle-related antigen Ki-67. Circulation 96:3360–3368

    PubMed  CAS  Google Scholar 

  3. Cabeza N, Li Z, Schulz C, Kremmer E, Massberg S, Bultmann A, Gawaz M (2004) Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes 53:2117–2121

    Article  PubMed  CAS  Google Scholar 

  4. Coller BS, Beer JH, Scudder LE, Steinberg MH (1989) Collagen-platelet interactions: evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins. Blood 74:182–192

    PubMed  CAS  Google Scholar 

  5. Cosemans JM, Kuijpers MJ, Lecut C, Loubele ST, Heeneman S, Jandrot-Perrus M, Heemskerk JW (2005) Contribution of platelet glycoprotein VI to the thrombogenic effect of collagens in fibrous atherosclerotic lesions. Atherosclerosis 181:19–27

    Article  PubMed  CAS  Google Scholar 

  6. De Meyer GR, Hoylaerts MF, Kockx MM, Yamamoto H, Herman AG, Bult H (1999) Intimal deposition of functional von Willebrand factor in atherogenesis. Arterioscler Thromb Vasc Biol 19:2524–2534

    PubMed  Google Scholar 

  7. Dietrich T, Perlitz C, Licha K, Stawowy P, Atrott K, Tachezy M, Meyborg H, Stocker C, Gräfe M, Fleck E, Schirner M, Graf K (2007) ED-B fibronectin (ED-B) can be targeted using a novel single chain antibody conjugate and is associated with macrophage accumulation in atherosclerotic lesions. Basic Res Cardiol 102:298–307

    Article  PubMed  CAS  Google Scholar 

  8. Farndale RW, Sixma JJ, Barnes MJ, De Groot PG (2004) The role of collagen in thrombosis and hemostasis. J Thromb Haemost 2:561–573

    Article  PubMed  CAS  Google Scholar 

  9. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L (1994) Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 23:1562–1569

    Article  PubMed  CAS  Google Scholar 

  10. Gawaz M (2004) Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res 61:498–511

    Article  PubMed  CAS  Google Scholar 

  11. Gawaz M, Konrad I, Hauser AI, Sauer S, Li Z, Wester HJ, Bengel FM, Schwaiger M, Schomig A, Massberg S, Haubner R (2005) Non-invasive imaging of glycoprotein VI binding to injured arterial lesions. Thromb Haemost 93:910–913

    PubMed  CAS  Google Scholar 

  12. Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Invest 115:3378–3384

    Article  PubMed  CAS  Google Scholar 

  13. Guyton JR, Klemp KF (1996) Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 16:4–11

    PubMed  CAS  Google Scholar 

  14. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K (2003) Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9:61–67

    Article  PubMed  CAS  Google Scholar 

  15. Katsuda S, Kaji T (2003) Atherosclerosis and extracellular matrix. J Atheroscler Thromb 10:267–274

    PubMed  CAS  Google Scholar 

  16. Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M (2002) A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196:887–896

    Article  PubMed  CAS  Google Scholar 

  17. Massberg S, Gawaz M, Gruner S, Schulte V, Konrad I, Zohlnhofer D, Heinzmann U, Nieswandt B (2003) A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 197:41–49

    Article  PubMed  CAS  Google Scholar 

  18. Massberg S, Konrad I, Bultmann A, Schulz C, Munch G, Peluso M, Lorenz M, Schneider S, Besta F, Muller I, Hu B, Langer H, Kremmer E, Rudelius M, Heinzmann U, Ungerer M, Gawaz M (2004) Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J 18:397–399

    PubMed  CAS  Google Scholar 

  19. Massberg S, Schurzinger K, Lorenz M, Konrad I, Schulz C, Plesnila N, Kennerknecht E, Rudelius M, Sauer S, Braun S, Kremmer E, Emambokus NR, Frampton J, Gawaz M (2005) Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 112:1180–1188

    Article  PubMed  CAS  Google Scholar 

  20. Moroi M, Jung SM (2004) Platelet glycoprotein VI: its structure and function. Thromb Res 114:221–233

    Article  PubMed  CAS  Google Scholar 

  21. Nieswandt B, Watson SP (2003) Platelet-collagen interaction: is GPVI the central receptor? Blood 102:449–461

    Article  PubMed  CAS  Google Scholar 

  22. Penz S, Reininger AJ, Brandl R, Goyal P, Rabie T, Bernlochner I, Rother E, Goetz C, Engelmann B, Smethurst PA, Ouwehand WH, Farndale R, Nieswandt B, Siess W (2005) Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI. FASEB J 19:898–909

    Article  PubMed  CAS  Google Scholar 

  23. Rother E, Brandl R, Baker DL, Goyal P, Gebhard H, Tigyi G, Siess W (2003) Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Circulation 108:741–747

    Article  PubMed  CAS  Google Scholar 

  24. Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8:1227–1234

    Article  PubMed  CAS  Google Scholar 

  25. Siess W, Zangl KJ, Essler M, Bauer M, Brandl R, Corrinth C, Bittman R, Tigyi G, Aepfelbacher M (1999) Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci USA 96:6931–6936

    Article  PubMed  CAS  Google Scholar 

  26. Theilmeier G, Michiels C, Spaepen E, Vreys I, Collen D, Vermylen J, Hoylaerts MF (2002) Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood 99:4486–4493

    Article  PubMed  CAS  Google Scholar 

  27. Von Hundelshausen P, Weber C (2007) Platelets as Immune Cells. Bridging inflammation and cardiovascular disease. Circ Res 100:27–40

    Article  CAS  Google Scholar 

  28. Weidtmann A, Scheithe R, Hrboticky N, Pietsch A, Lorenz R, Siess W (1995) Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2. Arterioscler Thromb Vasc Biol 15:1131–1138

    PubMed  CAS  Google Scholar 

  29. Zernecke A, Weber C (2005) Inflammatory mediators in atherosclerotic vascular disease. Basic Res Cardiol 100:93–101

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We acknowledge the excellent technical assistance of Heike Runge, Renate Hegenloh, Sandra Kerstan and Kirsten Langenbrink. The study was supported by grants of the Deutsche Forschungsgemeinschaft (Si 274/9), the DFG-graduate programs “Zellbiologische Mechanismen immunassoziierter Prozesse” (GK 794) and “Vaskuläre Biologie in der Medizin” (GK 438) to S.P. and K.D., and grants of the Deutsche Forschungsgemeinschaft (MA 2186/3-1) and Wilhelm-Vaillant-Stiftung to C.S.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Meinrad Gawaz MD.

Additional information

Returned for 1. Revision: 8 February 2008 1. Revision received: 18 February 2008

Electronic supplementary material

Below are the electronic supplementary materials.

ESM 1 (PDF 4,185 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schulz, C., Penz, S., Hoffmann, C. et al. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol 103, 356–367 (2008). https://doi.org/10.1007/s00395-008-0722-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00395-008-0722-3

Keywords

Navigation